Phase 1 Metastatic Pancreatic Cancer trials recruiting now
All Metastatic Pancreatic Cancer trials, every phase
9
Phase 1 recruiting
Other phases for Metastatic Pancreatic Cancer
Phase 1 Metastatic Pancreatic Cancer trials
- A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
- A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
- Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
- Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy
- Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC
- Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer
- SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
- mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer
Common questions
What does Phase 1 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.